Biotechs Avoid Harsh Sell-Off: Many Stocks in the Green

Biotechs Avoid Harsh Sell-Off: Many Stocks in the Green

About Raynovich Rod

Rod Raynovich is an experienced biotech investor an analyst with a focus in vaccines, tools, IVD’s and biopharmaceuticals. Prior to starting Raygent, he was a former technology transfer officer for UCLA and he has held various executive positions in the biotech and pharmaceutical industry, including senior positions at NASDAQ listed medical device companies. He was a founder and a former director of EPIX Medical. Prior to that Mr.Raynovich held management positions at JNJ and Abbott.

View all posts by Raynovich Rod

This article:  

Biotechs Avoid Harsh Sell-Off: Many Stocks in the Green

See which stocks are being affected by Social Media

Share this post